Guidance on applications for COVID-19 drug clinical trials under the Regulations: General requirements
This section of the guidance outlines additional responsibilites around consent of participants and registration.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records